Top 50 Biotechnology Angel Investors in Europe (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jonathan Milner
Angel
|
35 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $505k–$56M |
|
Charlie Songhurst
Angel
|
12 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $500k–$24M |
|
Nadav Rosenberg
Angel
|
6 | United Kingdom, France, Israel | Seed, Pre-Seed, Series A | Software, Biotechnology, Artificial Intelligence | $1.1M–$21M |
|
Stefano Bernardi
Angel
|
5 | Italy, United Kingdom, Canada | Seed, Pre-Seed | Blockchain, Software, Biotechnology | $100k–$18M |
|
Bernard Majoie
Angel
|
5 | France, Belgium | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Care | $1.4M–$2.7M |
|
Darrin Disley
Angel
|
5 | United Kingdom | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Big Data | $427k–$3.7M |
|
Annie Vereecken
Angel
|
5 | Belgium | Seed, Series A, Venture - Series Unknown | Medical, Biotechnology, Hospital | $2M–$30M |
|
Per Falholt
Angel
|
4 | Denmark | Pre-Seed, Series A, Seed | Biotechnology, Robotics, Biopharma | $5.9M–$20M |
|
Nadav Ben-Chanoch
Angel
|
4 | United States, France, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, Artificial Intelligence | $120k–$30M |
|
Andrea Dusi
Angel
|
4 | Italy, United States, United Kingdom | Seed, Pre-Seed, Angel | Biotechnology, FinTech, Software | $150k–$6M |
|
Sake Bosch
Angel
|
4 | The Netherlands, France, Israel | Seed, Series A, Series B | Software, E-Commerce, Biotechnology | $1.3M–$101M |
|
Milad Alucozai
Angel
|
4 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $113k–$60M |
|
Peder Nielsen
Angel
|
4 | United Kingdom | Seed, Convertible Note | Biotechnology | |
|
Jude Gomila
Angel
|
4 | United States, United Kingdom, India | Seed, Pre-Seed, Angel | Software, Information Technology, Artificial Intelligence | $70k–$4.7M |
|
Edward Lando
Angel
|
4 | United States, United Kingdom, France | Seed, Pre-Seed, Series A | Software, FinTech, Artificial Intelligence | $125k–$31M |
|
Pierre Drion
Angel
|
3 | Belgium | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Life Science | $8.6M–$23M |
|
Inaki Berenguer
Angel
|
3 | Spain, United States, United Kingdom | Seed, Angel, Pre-Seed | FinTech, Financial Services, E-Commerce | $233k–$9M |
|
Hugh Grant
Angel
|
3 | United Kingdom | Seed, Convertible Note | Biotechnology | |
|
DrPano Kroko Churchill
Angel
|
3 | United Kingdom | Angel, Series A | Health Care, Therapeutics, Biotechnology | $150k–$458k |
|
Nicholas Francis
Angel
|
3 | Denmark, United States | Seed, Series A | SaaS, Robotics, Software | $983k–$8.1M |
|
Mario Garcés
Angel
|
3 | Spain | Pre-Seed | Software, Metaverse, Neuroscience | $30k–$556k |
|
John Purdy
Angel
|
3 | Ireland | Seed, Pre-Seed, Venture - Series Unknown | SaaS, Software, Banking | $576k–$1.1M |
|
Ludwig Cramer-Klett
Angel
|
3 | Germany | Seed, Pre-Seed | Food Processing, Biotechnology, Food and Beverage | $2M–$2.8M |
|
Paul Wicks
Angel
|
3 | United Kingdom, United States, Japan | Seed, Pre-Seed, Series A | Software, Wellness, E-Commerce | $539k–$11M |
|
James Mellon
Angel
|
3 | United States, United Kingdom, Israel | Series A, Seed | Biotechnology, Food and Beverage, Food Processing | $894k–$47M |
|
Paul Forster
Angel
|
3 | United Kingdom, Germany, United States | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $1M–$26M |
|
Taavet Hinrikus
Angel
|
3 | United Kingdom, United States, Estonia | Seed, Series A, Series B | FinTech, Software, Financial Services | $1M–$50M |
|
Andrew Keys
Angel
|
3 | United States, India, Norway | Seed, Pre-Seed, Series A | Software, Finance, Blockchain | $1M–$34M |
|
David Helgason
Angel
|
3 | United States, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Artificial Intelligence | $242k–$30M |
|
Romain Sautrau
Angel
|
3 | France, Denmark | Series A, Seed, Pre-Seed | Biotechnology, Farming, Agriculture | $1.1M–$12M |
|
Jeffrey Dean
Angel
|
3 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Information Technology | $450k–$60M |
|
Ian Hogarth
Angel
|
3 | United Kingdom, United States, Germany | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $698k–$43M |
|
Schnidar Harald
Angel
|
3 | Austria | Seed, Angel, Pre-Seed | mHealth, Software, Biopharma | |
|
Alexandre Yazdi
Angel
|
2 | France, Turkey, Portugal | Seed, Pre-Seed | Software, Real Estate, Residential | |
|
Xavier Niel
Angel
|
2 | France, United States, Ecuador | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, SaaS | |
|
Others Others
Angel
|
2 | Spain, Germany, Ireland | Seed, Pre-Seed | Biotechnology, Software, B2B | |
|
Bruce Linton
Angel
|
2 | Canada, United States, Denmark | Seed, Post-IPO Equity, Pre-Seed | Health Care, Cannabis, Biotechnology | |
|
Nicholas Edwards
Angel
|
2 | United Kingdom | Seed | Medical, Health Care, Life Science | |
|
Sauli Törmälä
Angel
|
2 | Finland | Seed | Life Science, Biotechnology | |
|
Nico Wittenborn
Angel
|
2 | United States, Germany, France | Series A, Seed, Series B | Apps, Software, Mobile Apps | $1.6M–$88M |
|
Barbara Castellano
Angel
|
2 | Italy | Pre-Seed | Health Care, Biotechnology, Medical Device | |
|
Sophia Bendz
Angel
|
2 | Sweden, Denmark, United Kingdom | Seed, Pre-Seed, Angel | Health Care, Artificial Intelligence, Software | $348k–$5.9M |
|
Andreas Ehn
Angel
|
2 | Sweden, United States, Germany | Seed, Angel, Pre-Seed | Software, Internet, Financial Services | $911k–$7.7M |
|
Damien Lane
Angel
|
2 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Series A | Software, SaaS, Health Care | $532k–$16M |
|
Tim Dempsey
Angel
|
2 | United Kingdom | Seed, Series A | Software, SaaS, Financial Services | $150k–$13M |
|
Carsten Maschmeyer
Angel
|
2 | Germany, Austria, Switzerland | Seed, Angel, Series A | Software, Artificial Intelligence, Information Technology | $89k–$24M |
|
Chris Mairs
Angel
|
2 | United Kingdom, United States | Seed, Pre-Seed, Angel | Software, FinTech, E-Commerce | $392k–$5M |
|
Patrick Pichette
Angel
|
2 | United Kingdom, Germany, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $913k–$95M |
|
Hampus Jakobsson
Angel
|
2 | Sweden, Denmark, United States | Seed, Angel, Series A | Health Care, Software, Apps | $106k–$30M |
|
Ariel Poler
Angel
|
2 | United States, Spain, Mexico | Seed, Series A, Angel | Social Media, Software, Apps | $455k–$7.9M |
| Access all 50 angel investors in Europe Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon Discovery Group plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 63
- Round size: Seed $505k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 470+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Charlie Songhurst is a private investor in technology companies. He previously worked at Microsoft as Head of Corporate Strategy. Charlie attended the University of Oxford.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 266
- Round size: Seed $1.1M–$8M; Pre-Seed $500k–$5.1M; Series A $2.9M–$24M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mantic — Mantic is a world-class technical team on a mission to solve the next AI grand challenge: predicting global events with superhuman accuracy, and deploying this capability to power radically improved decision-making in business and government.
- Pilgrim — Pioneering a biologically enhanced future for humanity.
- Bleu Robotics — Bleu Robotics is an advanced AI and automation company that develops cutting-edge robot learning software designed to deploy humanoid robots seamlessly into industrial environments. Drawing on two decades of academic research in robotics and artificial intelligence, the company addresses the flexibility bottlenecks of traditional, fixed factory automation.
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Israel
Investor stats
- Total investments: 16
- Round size: Seed $1.1M–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Lindus Therapeutics — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Industry: Blockchain, Software, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Italy, United Kingdom, Canada
Investor stats
- Total investments: 18
- Round size: Seed $100k–$18M; Pre-Seed $874k–$2.2M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Freatic — Freatic builds decentralized products around untapped information markets.
- Niulinx — Politecnico di Milano spin-off building autonomous driving technology.
- Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Bernard Majoie - President @ Fournier-Majoie
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: France, Belgium
Investor stats
- Total investments: 6
- Round size: Seed $1.4M–$2.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Darrin Disley is based out of Cambridge, Cambridgeshire, and is the Executive Chairman and Director of Cardiogeni. Darrin previously worked at Mogrify as Chief Executive Officer, Director, and Investor. Darrin Disley attended the University of Cambridge.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Big Data
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 5
- Round size: Seed $427k–$3.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- bit.bio — Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development. The company uses a precision cell programming system to convert stem cells into defined human cell types and supplies a portfolio of reprogrammed cells, custom cell development services, and research-readyhuman cell models for scientific and pharmaceutical use. Bit.bio also supports integration of its products into partner research ecosystems and offers platform capabilities that help identify transcription factors for specific cell states. Its focus includes enabling scalable access to human cell models for experiments, screening workflows, and therapeutic investigation.
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Annie Vereecken
Show more...Investment focus
- Industry: Medical, Biotechnology, Hospital
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Belgium
Investor stats
- Total investments: 7
- Round size: Seed $2M–$6M; Series A $9.2M–$30M; Venture - Series Unknown $4.1M–$8.8M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.
Show more...Investment focus
- Industry: Biotechnology, Robotics, Biopharma
- Stage:Pre-Seed, Series A, Seed
- Geography: Denmark
Investor stats
- Total investments: 5
- Round size: Series A $5.9M–$20M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
- Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
- Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Nadav Ben-Chanoch
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 232
- Round size: Seed $500k–$6M; Pre-Seed $120k–$2.5M; Series A $4M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Swaap — We build & operate onchain trading systems. We are a group of scientists and technologists committed to build open systems.
- micro1 — We help companies hire and manage the best software engineers easily.
- Skedway — Skedway connects software, AI, sensors, displays and automation into one intelligent operational layer for the physical workplace.
Entrepreneur and investor. After working in management consulting, in 2006 he created Wish Days, known above all for the Emozione3 gift boxes. In April 2016, he sold the company to the Smartbox group with a millionaire exit. In 2017, together with Cristina Pozzi, already a partner in Wish Days he founded the no-profit organization Impactscool, with the aim to bring education on exponential technologies to Italian students and teachers. Impactscool was sold in 2025 with an exit to an Italian bank. Now his focus is manly on studying, exploring the potential of human beings, understanding true meaning of life, enjoying the passage of time. He is advisor of dozens of technological initiatives and business angels in 150+ startups focusing on clean tech. He is the author of the book “Come far fallire una startup ed essere fellici” – How to make a startup fail and be happy, published by Bompiani, Bestseller in 2018.
Show more...Investment focus
- Industry: Biotechnology, FinTech, Software
- Stage:Seed, Pre-Seed, Angel
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $150k–$6M; Angel $204k–$2.5M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- CitizenX — CitizenX is the secure and private platform that helps you diversify your passport portfolio, ensuring a safe future for you and your loved ones.
- Talyn Air — Inspired by two-stage rockets, our innovative eVTOL uses two flight vehicles to transform flight. Fixed-wing performance with VTOL capabilities.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sake Bosch is based out of Amsterdam, North Holland, and is the founder and managing partner of Prime Ventures. Sake previously worked at SlimPay as a board member.
Show more...Investment focus
- Industry: Software, E-Commerce, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: The Netherlands, France, Israel
Investor stats
- Total investments: 34
- Round size: Seed $1.3M–$7.2M; Series A $6.9M–$29M; Series B $7.1M–$101M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Alfa AI — Alfa AI sources, screens and shortlists candidates so your team only spends time on the people worth meeting.
- YGO.AI — Richer, more accurate content for every hotel you sell, created automatically and ready for AI assistants.
- TerraSpark — TerraSpark Energy specializing in software solutions for renewable energy asset management. The product, TerraSpark Hub, provides comprehensive oversight of commercial and technical data for green energy assets like solar and wind projects.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $1M–$7M; Pre-Seed $113k–$5M; Series A $13M–$60M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Peder Nielsen - Member of the Global Advisors Network @ Global Bio Fund
Show more...Investment focus
- Industry: Biotechnology
- Stage:Seed, Convertible Note
- Geography: United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Jude Gomila is based out of San Francisco, California and is the CEO and Founder of Ultrametric. Jude previously worked at Golden as a Founder. Jude Gomila attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 67
- Round size: Seed $1.4M–$4.7M; Angel $70k–$1.3M; Pre-Seed $1M–$2.9M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Clara — Primary care, supported by AI, that never closes, never rushes you, and never forgets the details.
- Dirac Labs — Universal Navigation powered by Quantum Sensing & AI
- Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 582
- Round size: Seed $950k–$6.3M; Pre-Seed $125k–$3.3M; Series A $5M–$31M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Humera — Humera - AI CAPTCHA That Knows You're Human
- Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
- Heywa Labs — Two products, one engine. Heywa Studio for businesses, Heywa for anyone with a question worth following.
Pierre Drion - CEO @ Petercam
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Belgium
Investor stats
- Total investments: 5
- Round size: Series A $8.6M–$16M; Series B $18M–$23M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Inaki Berenguer is based out of New York, New York and is the CEO and Co-Founder of MITO AI. Inaki previously worked at CoverWallet as a CEO and Co-Founder. Inaki Berenguer attended Massachusetts Institute of Technology.
Show more...Investment focus
- Industry: FinTech, Financial Services, E-Commerce
- Stage:Seed, Angel, Pre-Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 27
- Round size: Seed $500k–$9M; Angel $233k–$1M; Pre-Seed $1.2M–$2M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Goin — Goin is a Barcelona-based fintech platform founded in 2017 that provides a unified money optimization ecosystem combining automated savings, investments, digital assets, and rewards. The app enables users to aggregate multiple bank accounts via PSD2, centralizing financial data and automating decisions through its AI engine, gaIA. Goin integratesfinancial automation, portfolio tools, and cash-back incentives in a single interface used primarily by young European consumers. The company operates in a regulated environment, is registered with the Bank of Spain as a crypto service provider, and has expanded across Southern Europe. In 2025, Goin launched KernelPay, its B2B Banking-as-a-Service (BaaS) infrastructure for payments, accounts, and wallet management.
- Permisso — Bankflip is a mobile application that collects and processes income, tax, employment, and relevant data in real-time.
- Momento — Momento is an insurtech company with the objective of revolutionizing the insurance industry in Latin America, starting with car insurance. We want to make insurance easy and accessible for the underserved population in LATAM.
Hugh Grant is the Chief Executive Officer at H.B.Grant and Associates.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Seed, Convertible Note
- Geography: United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Pano Kroko is a legendary entrepreneur, Angel, VC and PE investor in innovation towards solving big problems. His investment emphasis is on Life Sciences, Biotech, Therapeutics, Medicine, Internet, Mobile, Communications, Clean Technology, Renewable Energy, and Environmental Finance. We have a quarterly Business Plan competition for placementin our early stage start up accelerator in Seattle Washington. We also run a program in Washington DC, and we have an Innovation Master Class Startup Weekend that runs Ten times a year in Seattle, Beijing, Silicon Valley, and in major Universities around the world.The Accelerator in Seattle & Silicon Valley is called American Angels, and the Accelerator in Washington DC is named H2O and both accept business plans and great ideas with Founders, and Executive teams right now. We would like to see StartUps in all of our areas of focus as well as anything else that is great and promising to solve Big Problems. Parallel to this we also run the CEP - Clean Energy Program incubator in Oxford UK, and the Biotech accelerator for genetics, stem cell applications, genomics, medicine, pharma and telomeres research in Cambridge UK.For our more traditional VC and PE work in the US, the American Venture Company in the US and the Investment Bank Green Capital Inc in the UK and Europe. These are our conduits of support for companies and also the Green Bonds Investments Plc. All of our organizations act as levers of positive change for impact investing, and as corporate environmental investment responsibility -- within the Finance community.In Seattle and in Silicon Valley we run the Accelerator and Early Stage Investment firm AMERICAN ANGELS where we have monthly pitches and demos for new StartUps and we also run a CEO roundtable to help promising Entrepreneurial leaders to succeed.If you or your company is interested in cooperation, presenting, funding, deal syndication or simply for submission of Executive Summaries and Business Plans for early stage angel funding and/or inclusion in the H2O Incubator/Accelerator or the Clean Energy program and the Biotech incubator, please contact us herewith: Mr Ruddy Wallace: envpar [at] gmail.com
Show more...Investment focus
- Industry: Health Care, Therapeutics, Biotechnology
- Stage:Angel, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 3
- Round size: Angel $150k–$458k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amrit Advanced Biotech — Company working in Genetics, Telomeres health applications, cancer mitigation and lengthening of....
Nicholas Francis is based out of Copenhagen, Hovedstaden, and is the Founder of Francis Family Funds. Nicholas previously worked at framebunker as a Co-Founder.
Show more...Investment focus
- Industry: SaaS, Robotics, Software
- Stage:Seed, Series A
- Geography: Denmark, United States
Investor stats
- Total investments: 4
- Round size: Seed $983k–$8.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Waterplan — Waterplan creates a water resilience planning platform for managing water availability in facilities. The company employs artificial intelligence to automatically collect operational data from businesses and combine it with local water satellite imagery to provide a real-time financial assessment of water risk and to offer modified mitigation andadaptation options.
- Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mario Garcés
Show more...Investment focus
- Industry: Software, Metaverse, Neuroscience
- Stage:Pre-Seed
- Geography: Spain
Investor stats
- Total investments: 3
- Round size: Pre-Seed $30k–$556k
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- The Mindkind — Unlock the future of AI with The Mindkind Project. Join us on our journey to achieve Artificial General Intelligence. Learn more about our mission now.
John Purdy
Show more...Investment focus
- Industry: SaaS, Software, Banking
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Ireland
Investor stats
- Total investments: 5
- Round size: Seed $576k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- dimply — The experience & engagement platform for financial enterprises.
- Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
- FlowForma — Unlock competitive advantage with FlowForma, the #1 no code digital process automation software & business process management tool. Get a free trial now!
Ludwig Cramer-Klett is an Entrepreneur and Investor.
Show more...Investment focus
- Industry: Food Processing, Biotechnology, Food and Beverage
- Stage:Seed, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 4
- Round size: Seed $2M–$2.7M; Pre-Seed $2M–$2.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Kynda — Kynda produces vegan foods and mycelium using accessible biotechnology for meat alternatives. They provide services for agri food companies, consumer packaged goods manufacturers, and biotech companies.
- Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham.
Show more...Investment focus
- Industry: Software, Wellness, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Japan
Investor stats
- Total investments: 17
- Round size: Seed $3M–$6.6M; Pre-Seed $539k–$1M; Series A $6.7M–$11M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Stelia — Stelia builds distributed AI platforms that scale globally. Research-driven intelligent systems for healthcare, education, and enterprise operations worldwide
- Epiminds — Epiminds develops multi-agent AI systems to run marketing end-to-end.
- Scooch — All-in-one subscription to eliminate hassle from your pet healthcare. From online assessment, health tracking and AI assistant to 24/7 vet support and vet-formulated treatments.
James Mellon is based out of San José, Islas Baleares, and is the co-founder and chairman of Juvenescence. James previously worked at Griffin Thornton as a trainee fund manager. James Mellon attended the University of Oxford.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 35
- Round size: Seed $894k–$20M; Series A $3M–$47M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Callers AI — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share is a new Caribbean “quirky” golden rum from the islands of Barbados and Jamaica.
Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 84
- Round size: Seed $1M–$6.9M; Pre-Seed $1.1M–$3.5M; Series A $3.7M–$26M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Wassist — Launch your AI sales agent on WhatsApp for Shopify in under 60 seconds. Recover 30-50% of abandoned carts and increase conversions by 3x.
- Capsa AI — Providing next-generation investors with a competitive edge.
- Applied Protein Labs — Applied Protein Labs is a biotech company based in the London, UK. The company specialises in the development of next-generation proteins for industry and agriculture.
Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD.
Show more...Investment focus
- Industry: FinTech, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 127
- Round size: Seed $1M–$7.9M; Series A $7M–$47M; Series B $23M–$50M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.
- Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
- Entrepreneurs First — We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more...Investment focus
- Industry: Software, Finance, Blockchain
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Norway
Investor stats
- Total investments: 14
- Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do. David's background is in programming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.
Show more...Investment focus
- Industry: Software, Gaming, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Denmark, Finland
Investor stats
- Total investments: 82
- Round size: Seed $1M–$8.5M; Pre-Seed $242k–$2.4M; Series A $5.4M–$30M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- ScyAI — ScyAI twins your assets and your coverage and shows exactly where they diverge.
- Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
- Flow Engineering — Requirements management, made collaborative
Romain Sautrau is a Investment Director at Supernova Invest. Romain attended INSEAD.
Show more...Investment focus
- Industry: Biotechnology, Farming, Agriculture
- Stage:Series A, Seed, Pre-Seed
- Geography: France, Denmark
Investor stats
- Total investments: 13
- Round size: Seed $1.4M–$2.7M; Series A $1.1M–$12M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Novolyze — Novolyze is a Food Safety company. They offer solutions to help the food industry manufacture safer food, while ensuring strong compliance with international Food Safety & Quality standards. Their research work mainly focuses on evaluating the inactivation of foodborne pathogens under different kinds of stress (heat, etc.). Based on thisexpertise, they have developed the first range of dried, ready-to-use surrogate bacteria, an innovation that allows the food industry to test the efficacy of microbial kill steps / intervention steps in real-life conditions. At Novolyze, they are at the forefront of Food Safety. Their cross-functional team of experts, mainly composed of food microbiologists and process engineers, is able to assist at multiple stages of a project. Novolyze relies on state-of-the-art infrastructures, installed in a pharmaceutical-grade environment at their R&D Center in Dijon, France.
- Antofenol — Antofénol is a post-harvest biocontrol company that directs and develops its work on the valorization of viticultural waste. Antofénol is an innovative biotechnology start-up providing ecological eco-extraction of plant matter.
- nextProtein — nextProtein is developing a large scale and sustainable insect based source of protein. The bioconversion of fly larvae fed with organic waste generates valuable feed components for fish, livestock and pets.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jeff Dean is the Co-founder and CEO of DiscoveryLoop. He previously worked at Google as Chief Scientist at Google DeepMind and Google Research. Jeff attended the University of Washington, where he earned a PhD in Computer Science.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 112
- Round size: Seed $2.5M–$34M; Pre-Seed $450k–$3M; Series A $10M–$60M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- G5 Labs — G5 is the semantic abstraction layer that makes AI-native software development compilable, mergeable, and governable for enterprises.
- Phinity Labs — Phinity Labs builds AI systems designed to fully automate the entire silicon microchip engineering process, spanning from original architectural concepts to final manufacturing preparation.
- Volantis — Volantis specializes in developing AI-driven semiconductor solutions. The company focuses on creating advanced systems that support high-performance computing for various applications, including networking, data centers, and edge computing. Volantis provides integrated hardware and software platforms designed to optimize processing power, energyefficiency, and scalability. Their technology aims to enhance the capabilities of existing infrastructure, making it adaptable to emerging computational demands. The company's solutions cater to industries that require robust, efficient computing power at scale.
Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 62
- Round size: Seed $1.7M–$14M; Pre-Seed $698k–$7.5M; Series A $11M–$43M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Cordless — Bridging the gap between voice and text
- Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Entrepreneur, Angel Investor, Scientist and Inventor
Show more...Investment focus
- Industry: mHealth, Software, Biopharma
- Stage:Seed, Angel, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 7
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Alexandre Yazdi - Co-Founder and CEO @ Voodoo
Show more...Investment focus
- Industry: Software, Real Estate, Residential
- Stage:Seed, Pre-Seed
- Geography: France, Turkey, Portugal
Investor stats
- Total investments: 17
- Lead/follow: no public data
Portfolio highlights
- ScorePlay — ScorePlay is an AI-powered media asset manager dedicated to sports. The MAM centralizes assets in a single media workspace, with AI-tagging. Distribute to athletes and sponsors automatically through app. Amplify your brand.
- Zamp — We take care of sales tax, so you don't have to.
- Sekai Studio — Creating mind blowing official entertainment anime fans have been dreaming about
Xavier Niel is based out of Paris, Ile-de-France and is the Co-Founder and CEO of NJJ Capital. Xavier previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: France, United States, Ecuador
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
- Genesis AI — Genesis AI operates as a physical AI lab and full-stack robotics company.
- Mobile Club — Mobile.club is a smartphone rental without obligation.
Others Others
Show more...Investment focus
- Industry: Biotechnology, Software, B2B
- Stage:Seed, Pre-Seed
- Geography: Spain, Germany, Ireland
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Conektto — Design, Build & Test API in minutes. Conektto is the industry's first API SDLC platform that intelligently generates artifacts.
- Gheorg — Around 1 million children in Australia have diagnosable anxiety. Two-thirds of them will never get the help they need. Gheorg is on a mission to change that. We're aiming to reduce childhood anxiety and our new app helps parents and children at home. Sign up to get the app on our website.
- Hooke Bio — Hooke Bio is a new Pharmaceutical company operating in the preclinical to early stages of drug discovery. It draws its strength from the close co-operation it has between its biologists and engineers. The engineers design, patent and test new microfluidic technology: the scientists apply the technology to finding new therapeutics.
Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc.Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influencedthe positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $150 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $500 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $600 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.
Show more...Investment focus
- Industry: Health Care, Cannabis, Biotechnology
- Stage:Seed, Post-IPO Equity, Pre-Seed
- Geography: Canada, United States, Denmark
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Omura — Discover heat-not-burn technology with Omura's dry herb vaporizer devices. Explore sustainable vaping options for hemp & whole flower CBD.
- Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
- Martello Technologies — Prioritize and resolve performance problems and optimize the Microsoft 365 and Teams user experience with Martello Vantage DX.
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Nico Wittenborn is an Investor at Adjacent.
Show more...Investment focus
- Industry: Apps, Software, Mobile Apps
- Stage:Series A, Seed, Series B
- Geography: United States, Germany, France
Investor stats
- Total investments: 47
- Round size: Seed $1.6M–$8.5M; Series A $6.9M–$40M; Series B $7.5M–$88M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Mirage — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
- Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
- Momentum — Finally, a real solution for major gift fundraising. Powered by AI.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Laura Iris Ferro
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
- CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Sophia Bendz is based out of Stockholm, Stockholms Lan and is the General Partner of Cherry Ventures. Sophia previously worked at The Ink Factory as a Member of the Board of Directors. Sophia Bendz attended Stockholm University.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Angel
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $408k–$5.9M; Angel $348k–$646k; Pre-Seed $800k–$2M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- 120ft — 120ft is a robotics and artificial intelligence company developing autonomous robotic systems and AI-powered solutions for industrial automation and manufacturing.
- Scape — Scape is an AI email client that proactively drafts replies and surfaces what matters. Built for professionals who live in their inbox.
- Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.
Andreas is working on a service that will connect people, time and places on the web. He also works as an independent consultant helping other startups with product strategy, technical infrastructure, scalability and recruiting as well as financial companies (venture capital and private equity) with technical due diligence and in other advisor roles. He was CTO at Spotify from the launch of the company in August 2006 until November 2009. Before that he worked at Stardoll as an engineer and project manager.
Show more...Investment focus
- Industry: Software, Internet, Financial Services
- Stage:Seed, Angel, Pre-Seed
- Geography: Sweden, United States, Germany
Investor stats
- Total investments: 19
- Round size: Seed $911k–$7.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Leetify — We help gamers identify their weaknesses, work on those weaknesses and track their progression.
- Prog.AI — Prog.AI helps to find developers based on their technical proficiency, libraries they have used, or even just the contributions they have made to GitHub projects.
- Single Technologies — SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq.
Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1, Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 39
- Round size: Seed $532k–$3.1M; Pre-Seed $660k–$1M; Series A $3.2M–$16M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Narchie — Create a home that's uniquely yours with Narchie. Shop sustainably, minimize waste, and find one-of-a-kind homeware items.
- Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
- Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester.
Show more...Investment focus
- Industry: Software, SaaS, Financial Services
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 18
- Round size: Seed $150k–$2.7M; Series A $6.4M–$13M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Mitra bio — We are transforming skin-care by approaching ageing as a disease to be fought. We are developing a genetic and epigenetic discovery platform to help skincare companies find and develop new compounds that actually fight the root cause of skin ageing.
- PPC Protect — Say goodbye to wasted ad spend and false conversions. Use Lunio to stave off click fraud and invalid users, safeguarding the quality of your traffic and driving better returns from paid media
- AeroCloud — Reinvent airport management with cloud-based software that enhances efficiency, unifies operations, and helps airports deliver a seamless, people-first experience.
Carsten Maschmeyer is based out of Munich, Bayern and is the Founder of MASCHMEYER GROUP. Carsten previously worked at AWD as a CEO and Founder.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Angel, Series A
- Geography: Germany, Austria, Switzerland
Investor stats
- Total investments: 86
- Round size: Seed $116k–$4.2M; Angel $89k–$548k; Series A $1.6M–$24M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Ivyclip — Ivyclip manufactures and sells flexible, break-resistant hair clips made from medical-grade materials that are designed to hold hair securely without causing pressure or pain when leaning back.
- Finperks — finperks is a prepaid infrastructure API for banks, neobanks, HR platforms, etc. in Europe. Access 1000+ brands across 30+ countries. Simplify contracts, settlements, and integrations to scale your prepaid, cashback, and employee benefits solutions.
- meinhaus.digital — meinhaus.digital provides an AI-powered platform to simplify planning, costing, and financing for home renovations and refurbishments of existing properties.
Chris Mairs - Venture Partner @ Entrepreneurs First
Show more...Investment focus
- Industry: Software, FinTech, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: United Kingdom, United States
Investor stats
- Total investments: 28
- Round size: Seed $791k–$5M; Angel $392k–$845k; Pre-Seed $900k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
- Briefcase — AI accounting software for UK businesses. Briefcase Ledger closes your books end to end, from receipts and bank reconciliation to VAT and reports, in one place.
- Borderless — Borderless is a workforce migration platform.It offers automation solutions that focuses on all aspects of hiring and onboarding of foreign workers, including recruitment, immigration, relocation, and compliance.
Patrick Pichette is based out of London, England, and is the Partner of Inovia Capital and also Board Member of Cohere. Patrick Pichette previously worked at Twitter as a Board of Directors. Patrick Pichette attended the University of Oxford.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 27
- Round size: Seed $913k–$10M; Series A $10M–$95M; Series B $15M–$95M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Mobai — Provider of attack detection, image manipulation detection and authentication. Strong and successful research team on biometrics.
- Kaedim — AI-powered 3D asset creation service delivering fast, production-ready 3D assets. Scale 3D pipelines without hiring, accelerate 3D game art production, and reduce 3D asset costs by up to 90%.
- Clove — Building a financial institution for how we live and work today.
Hampus Jakobsson is a General Partner at early stage climate tech venture fund Pale Blue Dot. Prior to co-founding Pale Blue Dot, Hampus was a Venture Partner at science fund Blue Yard and a prolific angel investor with >100 angel investments. He co-founded of The Astonishing Tribe (acquired by Blackberry in 2010 for $150m). He left Blackberry 2012 to found Brisk.io a sales productivity tool which folded 2016.
Show more...Investment focus
- Industry: Health Care, Software, Apps
- Stage:Seed, Angel, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 45
- Round size: Seed $310k–$5.5M; Angel $106k–$1.2M; Series A $2.3M–$30M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
- Mojo — Clinical-grade, AI-powered sperm analysis from the comfort of home. Test your sperm count, motility, morphology and much more with the Mojo kit. Check your fertility from home at low cost - without the need for clinic visits and awkward waiting rooms.
- Volta Greentech — Discover innovative solutions to reduce agricultural emissions with Volta Greentech's science-driven feed additives, promoting sustainable farming and planetary health.
Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of Freedom Financial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.
Show more...Investment focus
- Industry: Social Media, Software, Apps
- Stage:Seed, Series A, Angel
- Geography: United States, Spain, Mexico
Investor stats
- Total investments: 46
- Round size: Seed $455k–$7M; Angel $1M–$1.7M; Series A $3M–$7.9M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Goin — Goin is a Barcelona-based fintech platform founded in 2017 that provides a unified money optimization ecosystem combining automated savings, investments, digital assets, and rewards. The app enables users to aggregate multiple bank accounts via PSD2, centralizing financial data and automating decisions through its AI engine, gaIA. Goin integratesfinancial automation, portfolio tools, and cash-back incentives in a single interface used primarily by young European consumers. The company operates in a regulated environment, is registered with the Bank of Spain as a crypto service provider, and has expanded across Southern Europe. In 2025, Goin launched KernelPay, its B2B Banking-as-a-Service (BaaS) infrastructure for payments, accounts, and wallet management.
- Reloadly — Send gift cards, airtime & payouts globally with one API. Scalable, instant, developer-friendly platform for rewards and incentives.
- Openlytics — Openlytics is a Visual Data Platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape the direction ofthe product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Angel Investors in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 angel investors investing in Europe Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!